Evidence map›Paper›PMID 27556817›Full record

ArticleGene therapy2017

Hepatocyte growth factor-modified mesenchymal stem cells improve ischemia/reperfusion-induced acute lung injury in rats.

S Chen, X Chen, X Wu, S Wei, W Han, J Lin, M Kang, L Chen

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Gene therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Lung transplantation,Journal of thoracic disease · 2018
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

S ChenDepartment of Thoracic Surgery, The Affiliated Union Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
X ChenDepartment of Respiratory Diseases, The Affiliated Union Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
X WuSchool of Public Health, Fujian Medical University, Fuzhou, People's Republic of China.
S WeiBlood Bank, The Affiliated Union Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
W HanDepartment of Thoracic Surgery, The Affiliated Union Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
J LinDepartment of Thoracic Surgery, The Affiliated Union Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
M KangDepartment of Thoracic Surgery, The Affiliated Union Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
L ChenFujian Institute of Cardio-Thoracic Surgery, The Affiliated Union Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
Union Hospital · CNFujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulative evidence demonstrated that mesenchymal stem cell (MSC) engraftment could protect tissue injury from ischemia/reperfusion (I/R). Hepatocyte growth factor (HGF) has important roles in the cell and tissue repairment and regeneration. Here we investigated the enhanced effects of HGF-modified MSCs on I/R-induced acute lung injury. Rat bone marrow-derived MSCs were successfully transfected to express HGF. HGF modification did not affect the characteristics of MSCs, and increased MSC viability, and inhibit the proinflammatory phenotype of MSCs in the inflammatory condition. In the rat model of I/R-induced lung injury, MSC-HGF engraftment attenuated lung wet-to-dry weight ratio, enhanced PaO

Indexed as

Genetic TherapyMesenchymal Stem Cell TransplantationAnimalsCaspase 3Cells, CulturedHepatocyte Growth FactorHumansInterleukin-10LungMaleMalondialdehydeMesenchymal Stem CellsPeroxidaseProto-Oncogene Proteins c-bcl-2RatsRats, Sprague-DawleyCaspase 3Hepatocyte Growth FactorInterleukin-10MalondialdehydePeroxidaseProto-Oncogene Proteins c-bcl-2Tumor Necrosis Factor-alpha

Identifiers

PMID27556817
OpenAlexW2515795219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.